Cargando…

Roxithromycin-Associated Acute Thrombocytopenia

Patient: Female, 78-year-old Final Diagnosis: Acute autoimmune thrombocytopenia Symptoms: Petechial lesions of the palate • two hematomas of the tongue and purpuric macules with central crust in the abdomen and in the left lower limb Medication: — Clinical Procedure: — Specialty: Hematology • Pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Marco, Capecchi, Matteo, Lazzerini, Pietro E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255079/
https://www.ncbi.nlm.nih.gov/pubmed/34188012
http://dx.doi.org/10.12659/AJCR.932039
Descripción
Sumario:Patient: Female, 78-year-old Final Diagnosis: Acute autoimmune thrombocytopenia Symptoms: Petechial lesions of the palate • two hematomas of the tongue and purpuric macules with central crust in the abdomen and in the left lower limb Medication: — Clinical Procedure: — Specialty: Hematology • Pharmacology and Pharmacy OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Recently, some case reports have been published on the macrolide antimicrobials azithromycin and clarithromycin as the cause of thrombocytopenia. The publicly accessible databases of the European Medicine Agency and the WHO drug monitoring program contain dozens of reports of roxithromycin-associated thrombocytopenia. CASE REPORT: We described the case of a 78-year-old woman presenting to our unit with petechial lesions of the palate, 2 hematomas of the tongue, and purpuric macules in the abdomen and in the left lower limb 4 days after a course of roxithromycin. She presented to the Emergency Department with 3 out-of-range blood test results: neutrophils (11 960/mL; range: 1500–7000/mL), platelet count (3000/mL; range: 150 000–400 000/mL), and lactate dehydrogenase (379 IU/L; range: 135–225 IU/L). Thrombocytopenia occurred in the absence of aggregates and observed nucleolated lymphocytes. Lymphoproliferative pathologies and thrombotic microangiopathy were excluded by the hematologist. To rule out neoplastic lesions, an abdominal ultrasound examination was made. Antibody screening was performed for antinuclear antibodies, extractable nuclear antigen, antineutrophil cytoplasmic antibodies (all negative), and for Parvovirus B-19 (IgM negative, IgG positive), as well as HHV-6 and HHV-8 (both negative), to exclude an autoimmune or viral etiology. She recovered after intravenous methylprednisolone 60 mg/day and intravenous-immunoglobulin therapy 400 mg/kg/day. After 9 days, the patient was discharged with resolution of skin and buccal lesions. Her platelet count was 515 000/mL. CONCLUSIONS: To the best of our knowledge, this is the first case of roxithromycin-associated acute autoimmune thrombocytopenia reported in the medical literature. We suggest that clinicians should consider this drug to be among the possible causes of drug-induced thrombocytopenia.